The use of nanoparticles is revolutionizing the way we approach heart disease, offering more targeted and effective treatments. Nanotechnology and cardiovascular medicine are becoming increasingly intertwined, providing innovative solutions for drug delivery systems that directly target affected areas of the heart. By minimizing side effects and increasing the efficacy of treatments, these advances hold significant promise. Additionally, nanotechnology is improving diagnostic capabilities, allowing for earlier detection of cardiovascular conditions with greater accuracy. As research in nanomedicine continues to progress, it opens up exciting possibilities for tissue regeneration and the development of artificial blood vessels, offering hope for those with chronic cardiovascular issues.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China